New Synthesis of ‘FMCA’: A potential Anti-HBV Drug Candidate

FMCA

A new and potent anti-HBV drug candidate has been discovered by our research group here at Drug Discovery Group (College of Pharmacy, Department of Pharmaceutical and Biomedical Sciences) of the University of Georgia.   FMCA stands for Fluoro and Methylene substituted derivative of Carbocyclic Adenosine. It has a 2’-F substitution and 6’ exocyclic methylene group which distinguishes it from Aristeromycin, […]

» Read more